| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/20/2001 | WO2001068591A1 Carboxylic acid derivatives as ip antagonists |
| 09/20/2001 | WO2001068585A1 Novel amide compounds |
| 09/20/2001 | WO2001068063A2 Novel use of (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 09/20/2001 | WO2001034591A3 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/20/2001 | WO2001014369A3 Process for the preparation of paroxetin.hcl |
| 09/20/2001 | US20010023292 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example |
| 09/20/2001 | US20010023291 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 09/20/2001 | US20010023253 Novel compound |
| 09/20/2001 | US20010023250 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 09/20/2001 | DE10013126A1 New 6-aminoalkyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity |
| 09/20/2001 | CA2403149A1 2-phenylpyran-4-one derivatives |
| 09/20/2001 | CA2402402A1 Use of (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treating adverse effects of anti-parkinsonian drugs |
| 09/20/2001 | CA2373411A1 5-substituted arylpyrimidines |
| 09/19/2001 | EP1134214A1 Picolinamide derivatives and pest controllers containing the same as the active ingredient |
| 09/19/2001 | EP1133492A1 Process for the preparation of paroxetine hydrochloride |
| 09/19/2001 | EP1133491A1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 09/19/2001 | EP1133489A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 09/19/2001 | EP1133488A1 Propanoic acid derivatives as integrin inhibitors |
| 09/19/2001 | EP1133484A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 09/19/2001 | EP1133483A1 Il-5 inhibiting 6-azauracil derivatives |
| 09/19/2001 | EP1133481A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133480A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133479A1 Quinoline and quinoxaline compounds |
| 09/19/2001 | EP1133475A1 Substituted benzo de]isoquinoline-1,3-diones |
| 09/19/2001 | EP0869952B1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
| 09/19/2001 | EP0839144B1 Piperazine derivatives as therapeutic agents |
| 09/19/2001 | EP0800516B1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| 09/19/2001 | EP0612244B1 Endothelin receptor antagonists |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1313854A Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 09/19/2001 | CN1313853A Oxindole derivatives as growth hormone releasers |
| 09/19/2001 | CN1313284A N-(3-benzofuryl) urea derivative |
| 09/19/2001 | CN1313280A Benzheterocyclic derivatives |
| 09/19/2001 | CN1071332C Enterokinetic benzamide |
| 09/19/2001 | CN1071331C Anti-helicobacter acyl derivatives of azolones |
| 09/18/2001 | US6291687 Used aspartyl protease inhibitors of human immunodeficiency virus (hiv) |
| 09/18/2001 | US6291683 N-arloxyethyl-alkylamines for the treatment of depression |
| 09/18/2001 | US6291679 Process for preparing benzoperhydroisoindole compounds |
| 09/18/2001 | US6291672 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 09/18/2001 | US6291510 Small molecule inhibitors of rotamase enzyme activity |
| 09/18/2001 | US6291508 Potent ability to bind to retinoic acid receptors thus useful in treating psoriasis and rheumatoid arthritis. |
| 09/18/2001 | US6291500 Administering an antifungal agent |
| 09/18/2001 | US6291499 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
| 09/18/2001 | US6291489 Process for substituted pyridines |
| 09/18/2001 | US6291485 Treatment of post-ptca restenosis |
| 09/18/2001 | US6291482 N-hydroxyurea derivative and pharmaceutical composition containing the same |
| 09/18/2001 | US6291481 Conditions related to a hampered or impaired gastric emptying and more generally to treat conditions related to a hampered or impaired gastrointestinal transit. |
| 09/18/2001 | US6291480 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 09/18/2001 | US6291476 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 09/18/2001 | US6291456 Compounds and methods for modulation of estrogen receptors |
| 09/18/2001 | US6291451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 09/18/2001 | US6289745 High temperature insertion type flow element and mounting extension |
| 09/18/2001 | CA2236814C Quinoline and quinazoline compounds useful in therapy |
| 09/13/2001 | WO2001066539A1 Imidazol derivatives as raf kinase inhibitors |
| 09/13/2001 | WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 09/13/2001 | WO2001066523A1 6-chloro-3-pyridylmethylpropylamine derivatives, preparation process thereof and bactericides |
| 09/13/2001 | WO2001066521A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 09/13/2001 | WO2001066520A1 Indole derivatives, process for preparation of the same and use thereof |
| 09/13/2001 | WO2001066114A1 Novel methods using cholinesterase inhibitors |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | US20010021776 Spray drying |
| 09/13/2001 | US20010021719 2-phenyl-1- [4- (2-aminoethoxy) - benzyl] - indoles as estrogenic agents |
| 09/13/2001 | US20010021715 Gastrointestinal disorders |
| 09/13/2001 | US20010021709 Integrin inhibitors used to treat circulatory disorders, for thrombosis, myocardial infarct, coronary heart disease, arteriosclerosis, osteoporosis, pathological processes maintained or propagated by angiogenesis and tumor therapy |
| 09/13/2001 | US20010021708 Acylurea compound containing imidazolidine ring |
| 09/13/2001 | DE19954228A1 New epothilone derivatives used for treating e.g. malignant melanoma, breast carcinoma, psoriasis, multiple sclerosis and arthritis |
| 09/13/2001 | CA2402174A1 Indole derivatives, process for preparation of the same and use thereof |
| 09/12/2001 | EP1132379A1 Novel thiol derivatives, process for producing the same and utilization thereof |
| 09/12/2001 | EP1131318A1 Process for making 5-substituted pyrazoles using dithietanes |
| 09/12/2001 | EP1131315A1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 09/12/2001 | EP1131291A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 09/12/2001 | EP1131288A1 Pyrrolidine derivatives-ccr-3 receptor antagonists |
| 09/12/2001 | EP1044200A4 Preparation of terazosin hydrochloride dihydrate |
| 09/12/2001 | EP0891354B1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 09/12/2001 | EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 09/12/2001 | EP0863141B1 Substituted heteroaromatic derivatives |
| 09/12/2001 | EP0832066B1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 09/12/2001 | EP0794945B1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof |
| 09/12/2001 | CN1312807A Inhibitors of glycogen synthase kinase 3 |
| 09/12/2001 | CN1312803A Novel benzopykan or thiobenzopyran derivatives |
| 09/12/2001 | CN1312799A Bispiperidines as antithrombotic agents |
| 09/12/2001 | CN1312733A Reactor comprising a contact tube bundle |
| 09/12/2001 | CN1070701C Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
| 09/11/2001 | US6288247 Catalytic multistage process forming a racemic mixture of compounds |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288230 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands |
| 09/11/2001 | US6288228 Triazine angiogenesis inhibitors |
| 09/11/2001 | US6288102 Substituted phenylketoenols and their use as pesticides and herbicides |
| 09/11/2001 | US6288092 Triaryl compounds |
| 09/11/2001 | US6288085 Piperidine derivatives for treating psychoses |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288068 Administering 1,4-disubstited piperidine derivative; alzheimer*s disease, cognition activators; anticholinergic agents |
| 09/11/2001 | US6288066 Antidiabetic agents; oxidation, hydrolysis |
| 09/11/2001 | US6288059 Acylated hetero-alicyclic derivatives |
| 09/11/2001 | US6288058 Treating muscular, nervous system, psychological and gastrointestinal disorders |
| 09/11/2001 | CA2217171C New process for preparing (-)-trans-n-p-fluorobenzoylmethyl-4-(p-fluorophenyl)-3-¢¢3,4-(methylenedioxy)phenoxy!methyl!-piperidine |
| 09/11/2001 | CA2200742C Quinoxaline derivatives useful in therapy |
| 09/11/2001 | CA2115426C Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 09/07/2001 | WO2001064676A2 INHIBITORS OF p38-α KINASE |